SVB Leerink initiated coverage on DICE Therapeutics with a new price target
$DICE
Biotechnology: Pharmaceutical Preparations
Health Care
SVB Leerink initiated coverage of DICE Therapeutics with a rating of Outperform and set a new price target of $46.00